Literature DB >> 8699562

Clinical course of severe poisoning with thiomersal.

R Pfab1, H Mückter, G Roider, T Zilker.   

Abstract

CASE REPORT: A 44-year-old man ingested 83 mg/kg Thiomersal. He developed gastritis, renal tubular failure, dermatitis, gingivitis, delirium, coma, polyneuropathy and respiratory failure. Treatment was symptomatic plus gastric lavage and the oral chelating agents dimercaptopropane sulfonate and dimercaptosuccinic acid. The patient recovered completely. Maximum mercury concentrations were blood 14 mg/L, serum 1.7 mg/L, urine 10.7 mg/L, and cerebrospinal fluid 0.025 mg/L. Mercury concentration in blood declined with two velocities: first with half-time 2.2 days, then with half-time 40.5 days. The decline of mercury concentration in blood, urinary mercury excretion, and renal mercury clearance were not substantially influenced by chelation therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699562     DOI: 10.3109/15563659609013818

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  8 in total

1.  Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study.

Authors:  Mario Suwalsky; Pablo Zambrano; María José Gallardo; Fernando Villena; Malgorzata Jemiola-Rzeminska; Kazimierz Strzalka
Journal:  J Membr Biol       Date:  2016-10-13       Impact factor: 1.843

Review 2.  Vaccines without thiomersal: why so necessary, why so long coming?

Authors:  A J van't Veen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Thiomersal in vaccines: is removal warranted?

Authors:  C J Clements; L K Ball; R Ball; R D Pratt
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Efficacy of succimer chelation of mercury at background exposures in toddlers: a randomized trial.

Authors:  Yang Cao; Aimin Chen; Robert L Jones; Jerilynn Radcliffe; Kim N Dietrich; Kathleen L Caldwell; Shyamal Peddada; Walter J Rogan
Journal:  J Pediatr       Date:  2011-03       Impact factor: 4.406

5.  Towards a custom chelator for mercury: evaluation of coordination environments by molecular modeling.

Authors:  Juxia Fu; Ruth E Hoffmeyer; M Jake Pushie; Satya P Singh; Ingrid J Pickering; Graham N George
Journal:  J Biol Inorg Chem       Date:  2010-08-26       Impact factor: 3.358

Review 6.  Are neuropathological conditions relevant to ethylmercury exposure?

Authors:  Michael Aschner; Sandra Ceccatelli
Journal:  Neurotox Res       Date:  2009-09-16       Impact factor: 3.911

Review 7.  The three modern faces of mercury.

Authors:  Thomas W Clarkson
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

8.  Effect of thimerosal, methylmercury, and mercuric chloride in Jurkat T Cell Line.

Authors:  Gianpaolo Guzzi; Paolo D Pigatto; Francesco Spadari; Caterina A M La Porta
Journal:  Interdiscip Toxicol       Date:  2012-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.